 Diabetic Nephropathies
"Diabetic Nephropathies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE.
| Descriptor ID |
D003928
|
| MeSH Number(s) |
C12.777.419.192 C13.351.968.419.192 C19.246.099.875
|
| Concept/Terms |
Diabetic Nephropathies- Diabetic Nephropathies
- Nephropathies, Diabetic
- Nephropathy, Diabetic
- Diabetic Nephropathy
- Diabetic Kidney Disease
- Diabetic Kidney Diseases
- Kidney Disease, Diabetic
- Kidney Diseases, Diabetic
Diabetic Glomerulosclerosis- Diabetic Glomerulosclerosis
- Kimmelstiel-Wilson Syndrome
- Kimmelstiel Wilson Syndrome
- Syndrome, Kimmelstiel-Wilson
- Kimmelstiel-Wilson Disease
- Kimmelstiel Wilson Disease
- Nodular Glomerulosclerosis
- Glomerulosclerosis, Nodular
- Glomerulosclerosis, Diabetic
- Intracapillary Glomerulosclerosis
|
Below are MeSH descriptors whose meaning is more general than "Diabetic Nephropathies".
Below are MeSH descriptors whose meaning is more specific than "Diabetic Nephropathies".
This graph shows the total number of publications written about "Diabetic Nephropathies" by people in this website by year, and whether "Diabetic Nephropathies" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 2 | 2 | | 1999 | 1 | 1 | 2 | | 2000 | 1 | 1 | 2 | | 2002 | 0 | 1 | 1 | | 2003 | 1 | 0 | 1 | | 2004 | 1 | 3 | 4 | | 2005 | 0 | 1 | 1 | | 2006 | 3 | 0 | 3 | | 2007 | 1 | 0 | 1 | | 2008 | 2 | 0 | 2 | | 2009 | 3 | 3 | 6 | | 2010 | 4 | 3 | 7 | | 2011 | 2 | 2 | 4 | | 2012 | 3 | 0 | 3 | | 2013 | 4 | 0 | 4 | | 2014 | 9 | 2 | 11 | | 2015 | 8 | 0 | 8 | | 2016 | 7 | 1 | 8 | | 2017 | 7 | 1 | 8 | | 2018 | 10 | 5 | 15 | | 2019 | 10 | 3 | 13 | | 2020 | 13 | 2 | 15 | | 2021 | 6 | 1 | 7 | | 2022 | 13 | 0 | 13 | | 2023 | 6 | 0 | 6 | | 2024 | 7 | 3 | 10 | | 2025 | 5 | 3 | 8 | | 2026 | 5 | 0 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Diabetic Nephropathies" by people in Profiles.
-
Nair V, Minakawa A, Smith C, Berthier CC, Hartman J, Menon R, Fermin D, Otto EA, Gisch DL, Eadon MT, Jain S, Choi YJ, Pyle L, Eichinger F, Alakwaa FM, Rose MP, Subramanian L, El Saghir J, Beamish JA, Hodgin JB, Brosius FC, Bjornstad P, Nelson PJ, Harder JL, Werner T, Kretzler M, Schaub JA. Hypoxia inducible factor network reflects kidney disease progression in diabetes and sodium-glucose co-transporters inhibition. Signal Transduct Target Ther. 2026 Apr 21; 11(1).
-
Rønn PF, Svensson J, Wibaek R, Dabelea D, Hulman A. HbA1c trajectories and risk of albuminuria in children and adolescents with type 1 diabetes followed into adulthood - a joint modeling approach of Danish nationwide register data. J Diabetes Complications. 2026 May; 40(5):109317.
-
Mottl AK, Sawinski DL, Bjornstad P. Kidney and Cardiovascular Protection in Diabetes: Beyond Diabetes Typology. Am J Kidney Dis. 2026 May; 87(5):730-739.
-
Naik AS, Alakwaa FM, Nair V, McCown PJ, Schaub JA, Otto EA, Menon R, Annese F, Choi YJ, Hampson HE, Inge TH, Hartman J, Eddy S, Smith C, Hodgin JB, Inoki K, Srivastava SP, Al-Fagih K, Yoshida S, Goodrich JA, Cree MG, Narongkiatikhun P, Yuan L, Tommerdahl KL, Prasad P, van Raalte DH, Kelsey MM, Ryder JR, Dobbs TJ, Ladd P, Pennathur S, Nelson RG, Okabayashi Y, Puelles VG, Ferrence-Salo J, Beamish JA, Brosius FC, Nadeau KJ, Pyle L, Kretzler M, Bjornstad P. Metabolic surgery mitigates early kidney injury in obese youth with diabetes by suppressing mTORC1/JAK/STAT signaling. J Clin Invest. 2026 Apr 01; 136(7).
-
Kwok R, Kishore K, Zafari T, Koye DN, Hachem M, de Boer IH, Jeong TD, Min WK, Porrini E, Bjornstad P, Tham YC, MacIsaac RJ, Churilov L, Ekinci EI. RenoTrue: A diabetes-specific machine learning model to estimate glomerular filtration rate for people with diabetes. Diabetes Res Clin Pract. 2026 Mar; 233:113137.
-
Pruijm M, Belmar N, Bjornstad P, Cherney DZI, Das V, Gunnarsson T, Hodgin JB, Schytz PA, Tuttle KR, Kretzler M. REMODELing mechanistic trials for kidney disease: a multimodal, tissue-centered approach to understand the renal mechanism of action of semaglutide. Kidney Int. 2026 Jan; 109(1):6-16.
-
Perng W, Shu S, Nathan DM, Luchsinger JA, Gerszten RE, Middelbeek RJW, Kahn SE, Knowler WC, Dabelea D, Temprosa M. Shared and distinct metabolomics profiles associated with microvascular complications in the Diabetes Prevention Program Outcomes Study. Diabetologia. 2026 Jan; 69(1):103-113.
-
Kuehl M, Okabayashi Y, Wong MN, Gernhold L, Gut G, Kaiser N, Schwerk M, Gräfe SK, Ma FY, Tanevski J, Schäfer PSL, Mezher S, Sarabia Del Castillo J, Goldbeck-Strieder T, Zolotareva O, Hartung M, Delgado Chaves FM, Klinkert L, Gnirck AC, Spehr M, Fleck D, Joodaki M, Parra V, Shaigan M, Diebold M, Prinz M, Kranz J, Kux JM, Braun F, Kretz O, Wu H, Grahammer F, Heins S, Zimmermann M, Haas F, Kylies D, Wanner N, Czogalla J, Dumoulin B, Zolotarev N, Lindenmeyer M, Karlson P, Nyengaard JR, Sebode M, Weidemann S, Wiech T, Groene HJ, Tomas NM, Meyer-Schwesinger C, Kuppe C, Kramann R, Karras A, Bruneval P, Tharaux PL, Pastene D, Yard B, Schaub JA, McCown PJ, Pyle L, Choi YJ, Yokoo T, Baumbach J, Sáez PJ, Costa I, Turner JE, Hodgin JB, Saez-Rodriguez J, Huber TB, Bjornstad P, Kretzler M, Lenoir O, Nikolic-Paterson DJ, Pelkmans L, Bonn S, Puelles VG. Pathology-oriented multiplexing enables integrative disease mapping. Nature. 2025 08; 644(8076):516-526.
-
Beernink JM, Jongs N, Mosterd CM, Scholtes RA, Caldwell-McGee A, Casillas D, Driscoll L, Greasley PJ, Karlsson C, Hammarstedt A, Sridhar VS, Muskiet MHA, Laverman GD, Cherney DZI, Bjornstad P, van Raalte DH, Heerspink HJL. Effects of dapagliflozin on sodium excretion, blood pressure and volume status in patients with type 2 diabetes and/or chronic kidney disease: The DAPASALT trial. Diabetes Obes Metab. 2025 Aug; 27(8):4415-4426.
-
Bansal A, Chonchol M. Metabolic dysfunction-associated kidney disease: pathogenesis and clinical manifestations. Kidney Int. 2025 Aug; 108(2):194-200.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|